. . . . . . . "[Although underpowered, our data suggest that patients with HER2-positive breast cancer overexpressing Hsp90 should be investigated as a 'newer' molecular subtype with a significantly higher chance of pCR when receiving anti-Her2 agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:31+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .